University of Paris-Saclay-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2020

  1. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

    Nature Communications, Vol. 11, Núm. 1

  2. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)

    Nature Communications

2018

  1. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

    OncoImmunology, Vol. 7, Núm. 6

2017

  1. Trial watch: Immune checkpoint blockers for cancer therapy

    OncoImmunology, Vol. 6, Núm. 11

2016

  1. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Cancer Cell, Vol. 30, Núm. 1, pp. 147-160

2015

  1. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer

    Oncogene, Vol. 34, Núm. 23, pp. 3053-3062

  2. Trial Watch: Adoptive cell transfer for oncological indications

    OncoImmunology, Vol. 4, Núm. 11

  3. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

    OncoImmunology, Vol. 4, Núm. 4

  4. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

    OncoImmunology, Vol. 4, Núm. 4

  5. Trial watch: Naked and vectored DNA-based anticancer vaccines

    OncoImmunology, Vol. 4, Núm. 5

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. Consensus guidelines for the detection of immunogenic cell death

    OncoImmunology, Vol. 3, Núm. 9

  3. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

    OncoImmunology, Vol. 3, Núm. 2

  4. Trial Watch: Toll-like receptor agonists in oncological indications

    OncoImmunology, Vol. 3, Núm. 7

  5. Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

    OncoImmunology, Vol. 3, Núm. 1

  6. Trial watch: Adoptive cell transfer for anticancer immunotherapy

    OncoImmunology, Vol. 3, Núm. 5

  7. Trial watch: Chemotherapy with immunogenic cell death inducers

    OncoImmunology, Vol. 3, Núm. 3

  8. Trial watch: Dendritic cell-based anticancer therapy

    OncoImmunology, Vol. 3, Núm. 11, pp. e963424-1-e963424-16

  9. Trial watch: IDO inhibitors in cancer therapy

    OncoImmunology, Vol. 3, Núm. 10, pp. e957994-1-e957994-10

  10. Trial watch: Immunostimulatory cytokines in cancer therapy

    OncoImmunology, Vol. 3, Núm. 6